ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46467/ihc_cell_selected_60x60.jpg) | ![](/images/46467/104620_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PLIN1 | Perilipin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/24299/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/24299/53690_B_9_7_rna_selected_60x60.jpg) | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | ![](/images/2188/8447_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
LIPE | Lipase, hormone-sensitive | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images/17700/ihc_cell_selected_60x60.jpg) | ![](/images/17700/132027_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
PLIN4 | Perilipin 4 | Plasma proteins Predicted intracellular proteins
| | | ![](/images/44682/ihc_cell_selected_60x60.jpg) | ![](/images/44682/152672_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes Predicted intracellular proteins
| | | | ![](/images/73/1482_B_5_5_rna_selected_60x60.jpg) | Group enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60902/141575_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GPIHBP1 | Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/66302/150155_A_4_8_selected_60x60.jpg) | ![](/images/66302/149843_A_2_8_rna_selected_60x60.jpg) | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16662/ihc_cell_selected_60x60.jpg) | ![](/images/16662/37497_B_7_1_rna_selected_60x60.jpg) | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/3596/ihc_cell_selected_60x60.jpg) | ![](/images/3596/11016_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | ![](/images/6461/155193_B_7_1_rna_selected_60x60.jpg) | Tissue enriched |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/7305/18323_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | ![](/images/36573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57503/137455_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
ELOVL3 | ELOVL fatty acid elongase 3 | Enzymes Predicted membrane proteins
| | ![](/images/36236/1509_E4_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36236/158654_A_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/11952/30119_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
HEPACAM | Hepatic and glial cell adhesion molecule | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25486/59721_A_5_3_rna_selected_60x60.jpg) | Tissue enhanced |
IL2RA | Interleukin 2 receptor, alpha | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2419/6368_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
IL6 | Interleukin 6 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23406/54889_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/42434/134744_A_1_8_selected_60x60.jpg) | ![](/images/42434/134323_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
MT1A | Metallothionein 1A | Cancer-related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2161/5772_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | ![](/images/55780/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55780/129120_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9497/31482_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
PLXNA4 | Plexin A4 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/29919/157696_A_1_12_selected_60x60.jpg) | ![](/images/52141/140902_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
SNCG | Synuclein, gamma (breast cancer-specific protein 1) | Cytoskeleton related proteins Predicted intracellular proteins
| | ![](/images/40581/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/1452/4643_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
SOD3 | Superoxide dismutase 3, extracellular | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42110/91153_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50998/148399_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
TNFRSF4 | Tumor necrosis factor receptor superfamily, member 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16128/35585_A_8_5_rna_selected_60x60.jpg) | Tissue enhanced |